Why PMV Pharmaceuticals Inc (PMVP) Stock Is Rising
As of 2026-11-06, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 27.81%. Featured in our EPS revision report on 2026-09-10.
Why PMVP Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised PMV Pharmaceuticals Inc's next-year EPS growth estimate from 25.10% to 27.81% on 2026-10-30.
- ·Current-Year Growth: Projected at 23.87%, supporting the forward estimate revision.
News Context
PMVP’s rise is primarily tied to the analyst upgrade in next-year EPS growth estimates, which increased from 25.10% to 27.81% on October 30, 2026. No recent news headlines are available to identify a specific catalyst such as an earnings beat, guidance raise, contract win, or product launch. The current estimate remains at the upgraded 27.81% level, but the data do not show additional revisions beyond the initial upgrade.
Generated 2026-11-06 · news as of 2026-11-06
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.81%
- EPS growth this year
- 23.87%
- EPS next quarter (est)
- -$0.34
- Last price
- $1.27
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-06 | 27.81% | 23.87% | -$0.34 | $1.27 |
| 2026-11-05 | 27.81% | 23.87% | -$0.34 | $1.27 |
| 2026-11-04 | 27.81% | 23.87% | -$0.34 | $1.33 |
| 2026-11-03 | 27.81% | 23.87% | -$0.34 | $1.38 |
| 2026-11-02 | 27.81% | 23.87% | -$0.34 | $1.37 |
| 2026-10-31 | 27.81% | 23.87% | -$0.34 | $1.31 |
| 2026-10-30 | 27.81% | 23.87% | -$0.34 | $1.31 |
| 2026-10-29 | 25.10% | 19.26% | -$0.34 | $1.35 |
| 2026-10-28 | 25.10% | 19.26% | -$0.34 | $1.38 |
| 2026-10-27 | 25.10% | 19.26% | -$0.34 | $1.25 |
| 2026-10-26 | 25.10% | 19.26% | -$0.34 | $1.13 |
| 2026-10-23 | 25.10% | 19.26% | -$0.34 | $1.27 |
| 2026-10-22 | 25.10% | 19.26% | -$0.34 | $1.30 |
| 2026-10-21 | 25.10% | 19.26% | -$0.34 | $1.36 |
| 2026-10-20 | 25.10% | 19.26% | -$0.34 | $1.39 |
| 2026-10-19 | 25.10% | 19.26% | -$0.34 | $1.25 |
| 2026-10-16 | 25.10% | 19.26% | -$0.34 | $1.21 |
| 2026-10-15 | 25.10% | 19.26% | -$0.34 | $1.29 |
| 2026-10-14 | 25.10% | 19.26% | -$0.34 | $1.24 |
| 2026-10-13 | 25.10% | 19.26% | -$0.34 | $1.35 |
| 2026-10-12 | 25.10% | 19.26% | -$0.34 | $1.41 |
| 2026-10-11 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-10 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-09 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-08 | 25.10% | 19.26% | -$0.34 | $1.49 |
| 2026-10-07 | 25.10% | 19.26% | -$0.34 | $1.50 |
| 2026-10-06 | 25.10% | 19.26% | -$0.34 | $1.61 |
| 2026-10-05 | 25.10% | 19.26% | -$0.34 | $1.78 |
| 2026-10-04 | 25.10% | 19.26% | -$0.34 | $1.79 |
| 2026-10-03 | 25.10% | 19.26% | -$0.34 | $1.79 |
Reports Featuring PMVP
Screen Performance
Aggregate stats across all 2130 tickers our top-EPS-revision screen has flagged over the past 219 days.
- Median return since detection
- -3.9%
- % of tickers in the green
- 41%
- Median return on winners
- +23.3%
- Large revisions captured
- 2083
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did PMV Pharmaceuticals Inc (PMVP) stock go up recently?▾
PMV Pharmaceuticals Inc (PMVP) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 25.10% to 27.81% on 2026-10-30. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is PMV Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-11-06, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 27.81%, based on analyst consensus.
When was the latest EPS estimate revision for PMVP?▾
The most recent revision occurred on 2026-10-30, when analysts adjusted the next-year EPS growth estimate from 25.10% to 27.81%.
What sector and industry does PMV Pharmaceuticals Inc belong to?▾
PMV Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMVP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PMV Pharmaceuticals Inc (PMVP) appears here because it was detected by our daily top-EPS-revision-performer screen.